Literature DB >> 23098381

Validation and comparison of diagnostic accuracy of four screening tools for mental disorders in people seeking treatment for substance use disorders.

Brian Rush1, Saulo Castel, Bruna Brands, Tony Toneatto, Scott Veldhuizen.   

Abstract

This study aimed to validate and compare performance of four screening tools for mental disorders in a heterogeneous population seeking substance use treatment. A total of 544 clients were recruited prospectively from three treatment centres and completed the screening instruments followed by a reference standard psychiatric interview for research diagnosis. Performance relative to the reference standard was compared across instruments using receiver operator characteristic (ROC) analysis. Screening tools included the GAIN-SS-IDScr; the K6, the Psychiatric Sub-scale of the Addiction Severity Index, and the Psychiatric Diagnostic Screening Questionnaire. All the screening tools performed reasonably well detecting broad groupings of disorders-any past-month disorder, any depressive disorder, anxiety disorder or psychotic disorder, with the GAIN-SS-IDScr being most efficient due to its shorter length. Results strengthen previous validation data for each of the tools investigated and support their use in detecting mental disorders in the substance use treatment population specifically.
Copyright © 2013 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2012        PMID: 23098381     DOI: 10.1016/j.jsat.2012.08.221

Source DB:  PubMed          Journal:  J Subst Abuse Treat        ISSN: 0740-5472


  9 in total

1.  A psychometric assessment of the GAIN individual severity scale (GAIN-GISS) and short screeners (GAIN-SS) among adolescents in outpatient treatment programs.

Authors:  Brian D Stucky; Maria Orlando Edelen; Rajeev Ramchand
Journal:  J Subst Abuse Treat       Date:  2013-08-29

2.  Depression and anxiety in patients with heart disease and/or cancer based on the National Health Interview Survey.

Authors:  Mina M Benjamin; Robert Bossarte; Avirup Guha; Mahek Shah; Brijesh Patel
Journal:  Proc (Bayl Univ Med Cent)       Date:  2020-08-19

3.  Impact of Central Intake Development and System Change on Per Capita Child and Adolescent Mental Health Discharges from 2002 to 2017: Implications for Optimizing System Design by Shaping Demand.

Authors:  Karen Melathopolous; David Cawthorpe
Journal:  Perm J       Date:  2019-11-01

4.  Addiction Severity Index (ASI) summary scores: comparison of the Recent Status Scores of the ASI-6 and the Composite Scores of the ASI-5.

Authors:  Cécile M Denis; John S Cacciola; Arthur I Alterman
Journal:  J Subst Abuse Treat       Date:  2013-07-23

5.  A comparison of treatment outcomes for adolescent community reinforcement approach participants with and without co-occurring problems.

Authors:  Susan H Godley; Brooke D Hunter; Sergio Fernández-Artamendi; Jane Ellen Smith; Robert J Meyers; Mark D Godley
Journal:  J Subst Abuse Treat       Date:  2013-11-11

6.  Detecting change in psychiatric functioning in clinical trials for cocaine use disorder: sensitivity of the Addiction Severity Index and Brief Symptom Inventory.

Authors:  Brian D Kiluk; Corey R Roos; Mihaela Aslan; Ralitza Gueorguieva; Charla Nich; Theresa A Babuscio; Kathleen M Carroll
Journal:  Drug Alcohol Depend       Date:  2021-09-20       Impact factor: 4.492

7.  Psychiatric Comorbidity in Patients from the Addictive Disorders Assistance Units of Galicia: The COPSIAD Study.

Authors:  César Pereiro; Carlos Pino; Gerardo Flórez; Manuel Arrojo; Elisardo Becoña
Journal:  PLoS One       Date:  2013-06-18       Impact factor: 3.240

8.  Screening for more with less: Validation of the Global Appraisal of Individual Needs Quick v3 (GAIN-Q3) screeners.

Authors:  Michael L Dennis; Jordan P Davis
Journal:  J Subst Abuse Treat       Date:  2021-04-15

9.  Mental health, smoking, harm reduction and quit attempts - a population survey in England.

Authors:  Leonie S Brose; Jamie Brown; Debbie Robson; Ann McNeill
Journal:  BMC Public Health       Date:  2020-08-14       Impact factor: 3.295

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.